Cubist Systematic Strategies, LLC Liquidia Corp Call Options Transaction History

Cubist Systematic Strategies, LLC

  • $14.3 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.96 - $15.71 $270,296 - $355,046
-22,600 Reduced 16.05%
118,200 $1.42 Million
Q1 2024

May 15, 2024
BUY
$11.35 - $16.73 $1.21 Million - $1.78 Million
106,200 Added 306.94%
140,800 $2.08 Million
Q4 2023

Feb 14, 2024
BUY
$5.77 - $12.19 $199,641 - $421,774
34,600 New
34,600 $416,000

Others Institutions Holding LQDA

# of Institutions
163
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email